Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Investments (2016 - 2018)

Organogenesis Holdings has reported Long-Term Investments over the past 3 years, most recently at $316.3 million for Q3 2018.

  • For Q3 2018, Long-Term Investments rose 1.48% year-over-year to $316.3 million; the TTM value through Sep 2018 reached $316.3 million, up 1.48%, while the annual FY2017 figure was $312.5 million, 0.81% up from the prior year.
  • Long-Term Investments for Q3 2018 was $316.3 million at Organogenesis Holdings, roughly flat from $314.8 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $316.3 million in Q3 2018 and troughed at $310.0 million in Q4 2016.
  • A 3-year average of $312.4 million and a median of $312.1 million in 2017 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: grew 0.81% in 2017 and later grew 1.48% in 2018.
  • Year by year, Long-Term Investments stood at $310.0 million in 2016, then grew by 0.81% to $312.5 million in 2017, then increased by 1.21% to $316.3 million in 2018.
  • Business Quant data shows Long-Term Investments for ORGO at $316.3 million in Q3 2018, $314.8 million in Q2 2018, and $313.2 million in Q1 2018.